While in ERα−/PR−/HER2+ cells (KPL4) with intermediate CIN, the monotherapy and combined therapy induced an increase in CIN greater than 70% and a higher CH, which correlated to cell cytotoxicity (Figure 8). This evidence concerns the gene ESR1 and cervical squamous intraepithelial neoplasia.